Messenger Bio

Messenger Bio is a biotechnology company based in Melbourne, Australia, dedicated to advancing mRNA-based therapeutics and vaccines. The company offers a vertically integrated platform that encompasses mRNA design, synthesis, and lipid nanoparticle (LNP) encapsulation. Their core business includes providing high-purity, custom-engineered mRNA reagents and off-the-shelf products to global research institutions and pharmaceutical partners. Messenger Bio's proprietary technology focuses on enhancing the stability and translational efficiency of mRNA while reducing unintended immune activation. In addition to its role as a service provider, the company is actively developing an internal pipeline of mRNA candidates targeting oncology and infectious diseases. By streamlining the mRNA production process, Messenger Bio aims to lower the barriers to entry for researchers developing next-generation genetic medicines.